Search Results for: Galapagos NV Announces New Phase
Articles
July 6, 2017
Galapagos NV Announces New Phase 2 Study July 6, 2017
“We are pleased with the initiation of this new Phase 2 study with filgotinib," said Dr. Walid Abi-Saab, Chief Medical...
September 1, 2022
Qureight Announces World’s First Digital Biomarker for Lung Fibrosis September 1, 2022
For the first time, artificial intelligence (AI) using convolutional neural networks has been used to analyse trial data involving the lung disease idiopathic pulmonary fibrosis (IPF). The technology picked up….
March 14, 2022
OncoArendi Therapeutics Announces License Option Agreement With University of Michigan March 14, 2022
OncoArendi Therapeutics S.A. recently announced it has entered into an option-to-license agreement with Innovation Partnerships at the University of Michigan...
